• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.48% Nasdaq Up 0.29%

    GenVec, Inc. (GNVC)

    -NasdaqCM
    0.61 Down 0.02(3.25%) May 31, 3:43PM EDT
    Prev Close:0.63
    Open:0.65
    Bid:0.55 x 5000
    Ask:2.00 x 4000
    1y Target Est:5.00
    Beta:3.66433
    Earnings Date:Aug 5 - Aug 9 (Est.)
    Day's Range:0.61 - 0.65
    52wk Range:0.35 - 3.69
    Volume:18,422
    Avg Vol (3m):156,598
    Market Cap:13.87M
    P/E (ttm):N/A
    EPS (ttm):-0.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GNVC

    Comparison

    Symbol% ChgMkt Cap
    GNVCDown 3.25%13.87M
    MRKDown 0.39%155.73B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):18.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.30
    Quarterly EPS Est (Jun-16) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.06

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    GenVec, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback